IFNGR2, the receptor for interferon-gamma, plays a dual role in immune response modulation and is associated with the polarization of microglia and macrophages within the glioma microenvironment, influencing immunogenicity and the efficacy of immunotherapies [35,36]. This evidence concerns the gene IFNGR2 and central nervous system cancer.